URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Gary Morrow

Concepts (475)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Nausea
63
1982
155
13.000
Why?
Neoplasms
80
1978
723
11.900
Why?
Antineoplastic Agents
58
1982
625
8.390
Why?
Vomiting
39
1982
116
7.750
Why?
Fatigue
23
1996
125
7.300
Why?
Breast Neoplasms
27
1980
675
4.460
Why?
Antiemetics
20
1989
56
3.480
Why?
Antineoplastic Combined Chemotherapy Protocols
12
1985
430
2.450
Why?
Vomiting, Anticipatory
10
1988
21
2.250
Why?
Middle Aged
84
1978
9877
2.040
Why?
Humans
152
1966
36400
2.020
Why?
Quality of Life
21
1983
509
2.020
Why?
Radiotherapy
9
1982
198
2.010
Why?
Behavior Therapy
12
1982
109
1.660
Why?
Female
96
1968
19826
1.660
Why?
Aged
60
1978
7272
1.630
Why?
Exercise
5
2006
182
1.600
Why?
Patient Education as Topic
8
1983
219
1.470
Why?
Bone Density Conservation Agents
2
2009
51
1.420
Why?
Adult
67
1978
11345
1.380
Why?
Prostatic Neoplasms
4
2002
556
1.360
Why?
Cognition Disorders
2
2011
278
1.230
Why?
Aged, 80 and over
23
1996
2513
1.210
Why?
Depression
10
1983
431
1.180
Why?
Male
69
1968
19713
1.170
Why?
European Continental Ancestry Group
2
2007
226
1.160
Why?
African Americans
2
2007
214
1.130
Why?
Survivors
4
2009
114
1.050
Why?
Benzhydryl Compounds
3
2005
13
1.020
Why?
Complementary Therapies
3
2005
36
1.010
Why?
Social Support
5
1984
228
1.010
Why?
Tai Ji
3
2010
22
0.980
Why?
Acupressure
3
2003
16
0.930
Why?
Osteoporosis
3
2009
85
0.890
Why?
Health Behavior
3
1994
102
0.880
Why?
Treatment Outcome
17
1993
2623
0.860
Why?
Cisplatin
6
1992
94
0.840
Why?
Boronic Acids
1
2012
31
0.830
Why?
Antibodies, Monoclonal, Humanized
1
2012
89
0.820
Why?
Pyrazines
1
2012
35
0.820
Why?
Clinical Trials as Topic
8
1980
675
0.820
Why?
Ginger
1
2011
5
0.810
Why?
Perception
5
1984
64
0.810
Why?
Double-Blind Method
10
1998
998
0.810
Why?
Stress Disorders, Post-Traumatic
2
2005
72
0.810
Why?
Multiple Myeloma
1
2012
76
0.810
Why?
Phytotherapy
1
2011
18
0.800
Why?
Smoking
3
2009
390
0.800
Why?
Medically Underserved Area
2
2008
30
0.780
Why?
Serotonin Antagonists
5
1995
21
0.780
Why?
Colorectal Neoplasms
2
2009
136
0.770
Why?
Patient Satisfaction
5
2004
230
0.750
Why?
Ovarian Neoplasms
5
1992
107
0.750
Why?
Resistance Training
1
2010
7
0.750
Why?
Vitamin D
1
2011
70
0.730
Why?
Autonomic Nervous System
4
1992
70
0.720
Why?
Questionnaires
14
1982
998
0.720
Why?
Exercise Tolerance
1
2009
11
0.710
Why?
Osteoporotic Fractures
1
2009
14
0.710
Why?
Health Status Disparities
1
2010
48
0.700
Why?
Stress, Psychological
3
1983
283
0.700
Why?
Adaptation, Psychological
9
1978
207
0.690
Why?
Sleep Initiation and Maintenance Disorders
2
1985
45
0.690
Why?
Calcitriol
1
2009
80
0.680
Why?
Family
2
2007
201
0.680
Why?
Sleep Disorders
3
2002
70
0.670
Why?
Gene Expression Regulation, Neoplastic
1
2011
254
0.670
Why?
Anxiety
3
1978
106
0.650
Why?
Radiation Injuries
2
2005
130
0.640
Why?
Ondansetron
4
1995
11
0.630
Why?
Cognition
2
1986
227
0.610
Why?
Hot Flashes
3
2000
28
0.610
Why?
Paroxetine
2
2003
11
0.610
Why?
Fatigue Syndrome, Chronic
1
2007
10
0.590
Why?
Needs Assessment
1
2008
92
0.580
Why?
Community Health Services
2
2006
77
0.580
Why?
Attitude
3
1982
64
0.580
Why?
Bone and Bones
1
2010
357
0.570
Why?
Hydrocortisone
2
1989
131
0.570
Why?
Psychophysiology
1
2006
15
0.560
Why?
Antineoplastic Agents, Hormonal
2
2000
46
0.550
Why?
Skin Diseases
1
2007
119
0.550
Why?
Emotions
1
2006
89
0.540
Why?
Therapeutic Touch
1
2005
3
0.520
Why?
Conditioning, Classical
3
1991
33
0.520
Why?
Hypothalamo-Hypophyseal System
2
2001
55
0.510
Why?
Motion Sickness
6
1984
8
0.500
Why?
Prevalence
6
1992
541
0.490
Why?
Patient Compliance
5
1982
171
0.480
Why?
Social Adjustment
6
1978
88
0.470
Why?
Tamoxifen
2
2000
84
0.470
Why?
Serotonin Uptake Inhibitors
1
2003
35
0.470
Why?
Vagus Nerve
2
2000
40
0.460
Why?
Primary Health Care
1
2008
492
0.440
Why?
Research Design
5
1991
333
0.440
Why?
Granisetron
3
1995
7
0.440
Why?
Cytokines
4
2001
572
0.440
Why?
Platinum Compounds
1
2002
7
0.430
Why?
Doxorubicin
6
2003
109
0.430
Why?
Family Relations
1
2003
46
0.430
Why?
Patients
2
1984
47
0.430
Why?
Sex Factors
5
1983
584
0.420
Why?
United States
11
1979
2630
0.420
Why?
Risk Factors
9
1991
2318
0.410
Why?
Pilot Projects
4
2004
441
0.400
Why?
Acupuncture Therapy
3
2002
12
0.390
Why?
Physician-Patient Relations
9
1979
365
0.380
Why?
Time Factors
7
1982
3201
0.370
Why?
Age Factors
7
1984
1121
0.370
Why?
Clonidine
1
2000
32
0.370
Why?
Adrenergic alpha-Agonists
1
2000
37
0.370
Why?
Postmenopause
1
2000
43
0.360
Why?
Carboplatin
4
1995
30
0.350
Why?
Receptors, Serotonin
2
1998
12
0.350
Why?
Serotonin
3
2001
99
0.350
Why?
Bone Density
2
2009
115
0.350
Why?
Models, Psychological
4
1980
90
0.330
Why?
Pain
3
2006
382
0.330
Why?
Medicare
2
2009
130
0.330
Why?
Tobacco Smoke Pollution
2
2008
57
0.330
Why?
Hypnosis
3
1988
16
0.330
Why?
Attitude to Health
6
1978
209
0.320
Why?
Parasympathetic Nervous System
4
1992
15
0.320
Why?
Desensitization, Psychologic
3
1982
4
0.310
Why?
Severity of Illness Index
6
2000
919
0.310
Why?
Randomized Controlled Trials as Topic
2
1992
409
0.310
Why?
New York
5
2006
1282
0.300
Why?
Statistics as Topic
3
1980
187
0.300
Why?
Radiodermatitis
2
2006
8
0.290
Why?
Biological Markers
2
2009
564
0.290
Why?
Analysis of Variance
3
2003
725
0.290
Why?
Neoplasm Staging
5
1999
335
0.290
Why?
Psychometrics
4
1984
221
0.280
Why?
Retrospective Studies
5
1986
2260
0.280
Why?
Placebo Effect
2
2006
34
0.280
Why?
Health Knowledge, Attitudes, Practice
1
2000
279
0.280
Why?
Psychotherapy, Group
3
1999
27
0.280
Why?
Communication
3
2006
271
0.280
Why?
Odds Ratio
4
2008
304
0.280
Why?
Palliative Care
1
1998
159
0.280
Why?
Health Status Indicators
2
2002
108
0.270
Why?
Prognosis
6
1979
1080
0.270
Why?
Adolescent
14
1981
4752
0.270
Why?
Geriatric Assessment
3
2009
150
0.260
Why?
Follow-Up Studies
8
1992
1857
0.260
Why?
Behavioral Sciences
1
1994
5
0.250
Why?
Receptors, Serotonin, 5-HT3
3
1998
8
0.250
Why?
Cyclohexanecarboxylic Acids
2
2004
47
0.240
Why?
Clinical Protocols
1
1994
105
0.240
Why?
Amines
2
2004
63
0.240
Why?
Dose-Response Relationship, Drug
2
2001
1138
0.240
Why?
Serotonin 5-HT3 Receptor Antagonists
2
2004
7
0.240
Why?
Prochlorperazine
3
2005
11
0.230
Why?
gamma-Aminobutyric Acid
2
2004
98
0.230
Why?
Skin
2
2006
381
0.230
Why?
Logistic Models
3
2009
578
0.220
Why?
Drug Therapy, Combination
3
1979
390
0.220
Why?
Meta-Analysis as Topic
1
1992
35
0.220
Why?
Parents
3
1978
163
0.220
Why?
Social Environment
2
1981
92
0.220
Why?
Blood Pressure
5
1978
474
0.210
Why?
Drug Administration Schedule
2
2009
369
0.210
Why?
Regression Analysis
4
1995
524
0.210
Why?
Behavioral Medicine
2
1982
11
0.210
Why?
Longitudinal Studies
3
1991
390
0.210
Why?
Oncologic Nursing
1
1992
8
0.210
Why?
Psychology, Clinical
1
1992
5
0.210
Why?
Informed Consent
3
1980
82
0.210
Why?
Relaxation Therapy
3
1982
16
0.210
Why?
Sick Role
4
1991
47
0.210
Why?
Comorbidity
3
2006
374
0.210
Why?
Circadian Rhythm
3
1989
85
0.210
Why?
Drug Therapy
1
1992
46
0.200
Why?
Medical Oncology
1
1992
49
0.200
Why?
Massage
1
2011
9
0.200
Why?
Feasibility Studies
2
1999
205
0.200
Why?
Cyclophosphamide
4
1985
173
0.190
Why?
Risk
3
1982
358
0.190
Why?
Interleukin-6
2
2006
340
0.190
Why?
Vitamin D Deficiency
1
2011
35
0.190
Why?
Interleukin-8
1
2011
111
0.190
Why?
Energy Metabolism
1
2011
137
0.180
Why?
Dentate Gyrus
1
2010
26
0.180
Why?
Central Nervous System Stimulants
1
2010
42
0.180
Why?
Chemokine CCL2
1
2011
128
0.180
Why?
Collagen Type I
1
2010
52
0.180
Why?
Intervention Studies
1
2009
30
0.180
Why?
Sexual Dysfunctions, Psychological
1
2009
2
0.180
Why?
Peptides
3
1966
288
0.170
Why?
Muscle Strength
1
2009
26
0.170
Why?
Tumor Markers, Biological
1
2011
228
0.170
Why?
Home Care Services
1
2009
38
0.170
Why?
Food Preferences
1
1989
12
0.170
Why?
Body Image
1
2009
28
0.170
Why?
Insulin-Like Growth Factor I
1
2010
106
0.170
Why?
Blood-Brain Barrier
1
2010
108
0.170
Why?
Wrist
3
2002
49
0.170
Why?
Bulimia
1
1989
18
0.170
Why?
Conditioning (Psychology)
2
1984
29
0.170
Why?
Adrenocorticotropic Hormone
1
1989
75
0.170
Why?
Frail Elderly
1
2009
59
0.170
Why?
Fetal Death
1
2008
57
0.170
Why?
Child
6
1978
4086
0.170
Why?
Placebos
3
2000
182
0.170
Why?
Continental Population Groups
1
2009
117
0.160
Why?
Brain Neoplasms
2
1985
282
0.160
Why?
Memory
1
2009
102
0.160
Why?
Psychotherapy, Brief
1
2008
7
0.160
Why?
Infertility, Female
1
2008
57
0.160
Why?
Self Concept
1
2009
103
0.160
Why?
Awareness
1
2008
35
0.160
Why?
Bone Resorption
1
2010
243
0.160
Why?
Activities of Daily Living
2
2001
255
0.160
Why?
Interleukin-1
2
2006
222
0.160
Why?
Insulin
1
2011
670
0.150
Why?
Sickness Impact Profile
1
2007
40
0.150
Why?
Health Promotion
2
1980
152
0.150
Why?
Outcome and Process Assessment (Health Care)
1
2008
84
0.150
Why?
Patient Care
1
2008
40
0.150
Why?
Attention
1
2009
148
0.150
Why?
Survival Rate
1
2009
619
0.150
Why?
Drug Eruptions
1
2007
27
0.150
Why?
Young Adult
2
2008
1074
0.150
Why?
Case-Control Studies
1
2009
618
0.150
Why?
Life Style
1
2008
87
0.150
Why?
Life Change Events
1
2008
106
0.150
Why?
Cognitive Therapy
1
2007
40
0.140
Why?
Arousal
1
2006
57
0.140
Why?
Pituitary-Adrenal System
2
1989
36
0.140
Why?
National Institutes of Health (U.S.)
1
2006
63
0.140
Why?
Curcumin
1
2006
25
0.140
Why?
Community Health Centers
2
2000
25
0.140
Why?
Radiation-Protective Agents
1
2006
41
0.140
Why?
Academic Medical Centers
2
2003
89
0.140
Why?
Radiation Injuries, Experimental
1
2006
88
0.130
Why?
Muscles
1
2007
348
0.130
Why?
Program Evaluation
1
2006
205
0.130
Why?
Choice Behavior
1
2006
47
0.130
Why?
Psychological Tests
4
1978
80
0.130
Why?
Immune Tolerance
1
1986
144
0.130
Why?
Transcutaneous Electric Nerve Stimulation
1
2005
8
0.130
Why?
Menopause
1
2005
43
0.130
Why?
Multivariate Analysis
4
1992
531
0.130
Why?
Antidepressive Agents, Second-Generation
1
2005
14
0.130
Why?
Professional-Patient Relations
2
2000
45
0.130
Why?
Data Interpretation, Statistical
2
1992
155
0.130
Why?
Self Efficacy
1
2005
44
0.130
Why?
Valsalva Maneuver
3
1995
12
0.120
Why?
Decision Making
2
1984
224
0.120
Why?
Affective Symptoms
1
2005
52
0.120
Why?
Aging
1
2011
706
0.120
Why?
Antidepressive Agents
2
1979
93
0.120
Why?
Demography
3
1992
97
0.120
Why?
Chronic Disease
1
2007
530
0.120
Why?
Behavior
1
2004
54
0.120
Why?
Lung Diseases
1
1986
224
0.120
Why?
Sympathetic Nervous System
2
1992
115
0.120
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.120
Why?
Psychotherapy
1
2005
87
0.120
Why?
Self-Assessment
3
1984
52
0.120
Why?
Acetates
1
2004
65
0.120
Why?
Patient Dropouts
2
1981
28
0.120
Why?
Physical Stimulation
1
2003
56
0.120
Why?
Educational Status
2
1980
172
0.110
Why?
Administration, Oral
2
2000
309
0.110
Why?
Glucocorticoids
1
2005
166
0.110
Why?
Health Status
3
2009
269
0.110
Why?
Conflict (Psychology)
1
2003
21
0.110
Why?
Cross-Sectional Studies
4
2002
621
0.110
Why?
Stress Disorders, Traumatic
1
2002
4
0.110
Why?
Occult Blood
1
1982
8
0.110
Why?
Electroacupuncture
1
2002
2
0.110
Why?
Risk Assessment
2
1984
878
0.110
Why?
Chi-Square Distribution
1
2003
333
0.110
Why?
Psychiatric Status Rating Scales
1
2003
333
0.110
Why?
Self Care
1
1982
60
0.100
Why?
Anemia
1
2001
77
0.100
Why?
Stomach
1
2001
67
0.100
Why?
Records as Topic
1
1980
7
0.100
Why?
Outcome Assessment (Health Care)
1
2003
293
0.090
Why?
Palpation
1
1980
13
0.090
Why?
Heart Rate
3
1978
470
0.090
Why?
Quality-Adjusted Life Years
1
2000
50
0.090
Why?
Sampling Studies
1
2000
47
0.090
Why?
Metoclopramide
1
1999
8
0.090
Why?
Syndrome
2
2009
210
0.090
Why?
Breast
1
1980
65
0.090
Why?
Reproducibility of Results
3
1992
884
0.090
Why?
Cold Temperature
1
1999
96
0.090
Why?
Body Temperature
2
1984
65
0.090
Why?
Posture
1
1999
113
0.090
Why?
Adenosine Triphosphate
1
2001
414
0.080
Why?
Data Collection
1
2000
214
0.080
Why?
Emetics
1
1998
4
0.080
Why?
Dexamethasone
2
2005
183
0.080
Why?
Catecholamines
1
1978
80
0.080
Why?
Fluorouracil
2
1985
76
0.080
Why?
Evidence-Based Medicine
1
1999
199
0.080
Why?
Carcinoma
1
1999
191
0.080
Why?
Hydroxyproline
2
1966
25
0.080
Why?
Weight Loss
2
2004
75
0.070
Why?
Animals
6
1967
16270
0.070
Why?
Pallor
2
1992
6
0.070
Why?
Pulse
2
1992
27
0.070
Why?
Hodgkin Disease
1
1978
153
0.070
Why?
Cardiovascular System
1
1996
47
0.070
Why?
Sensitivity and Specificity
1
2000
905
0.070
Why?
Signal Transduction
1
2006
1626
0.070
Why?
Prospective Studies
3
1982
1677
0.070
Why?
Counseling
2
1982
70
0.070
Why?
Ambulatory Care
1
1996
152
0.060
Why?
Indoles
1
1995
104
0.060
Why?
Disease Susceptibility
2
1984
80
0.060
Why?
Health Surveys
2
2004
198
0.060
Why?
Infant, Newborn
3
1966
1831
0.060
Why?
Affect
2
1986
78
0.060
Why?
Personality Inventory
2
1999
151
0.060
Why?
Vestibule, Labyrinth
2
1984
82
0.060
Why?
Research
1
1994
179
0.060
Why?
Anxiety Disorders
2
1985
55
0.060
Why?
Mental Disorders
3
1979
346
0.060
Why?
Psychotropic Drugs
2
1979
38
0.060
Why?
Patient Selection
1
1994
209
0.060
Why?
Quinuclidines
1
2012
5
0.060
Why?
Receptors, Neurokinin-1
1
2012
7
0.060
Why?
Blood Volume
1
1992
52
0.050
Why?
Intention to Treat Analysis
1
2012
10
0.050
Why?
Morpholines
1
2012
43
0.050
Why?
Mice, Inbred C57BL
2
2006
1683
0.050
Why?
Lung Neoplasms
1
1996
428
0.050
Why?
Isoquinolines
1
2012
63
0.050
Why?
Mice
3
2006
6103
0.050
Why?
Alprazolam
1
1991
1
0.050
Why?
Muscle Relaxation
1
1991
23
0.050
Why?
Nutrition Disorders
1
2011
17
0.050
Why?
Pregnancy
2
2004
1962
0.050
Why?
Individuality
1
1991
10
0.050
Why?
Hearing Disorders
1
2011
25
0.050
Why?
Body Temperature Regulation
1
1991
29
0.050
Why?
Accidental Falls
1
2011
43
0.050
Why?
Urinary Incontinence
1
2011
46
0.050
Why?
Infusions, Intravenous
1
1991
139
0.050
Why?
Benzodiazepines
1
2010
26
0.050
Why?
Memory Disorders
1
2011
48
0.050
Why?
Bromodeoxyuridine
1
2010
67
0.050
Why?
Vision Disorders
1
2011
70
0.050
Why?
Neurogenesis
1
2010
30
0.050
Why?
Paclitaxel
1
2010
57
0.040
Why?
Physicians
2
1979
159
0.040
Why?
Confounding Factors (Epidemiology)
1
2009
58
0.040
Why?
Disabled Persons
1
2009
52
0.040
Why?
Mastectomy
1
2009
44
0.040
Why?
Corticotropin-Releasing Hormone
1
1989
45
0.040
Why?
Socioeconomic Factors
2
1981
383
0.040
Why?
Residence Characteristics
1
2009
66
0.040
Why?
Vitamin B 12 Deficiency
1
1968
6
0.040
Why?
Eating
1
1989
83
0.040
Why?
Metabolism, Inborn Errors
1
1968
9
0.040
Why?
Malonates
1
1968
7
0.040
Why?
Hypothalamus
1
1989
89
0.040
Why?
Women's Health
1
2009
61
0.040
Why?
Community Mental Health Centers
1
2008
13
0.040
Why?
National Cancer Institute (U.S.)
1
2007
12
0.040
Why?
Body Weight
1
1989
338
0.040
Why?
Urban Health
1
2008
57
0.040
Why?
Maternal Exposure
1
2008
97
0.040
Why?
Child, Preschool
2
1981
2612
0.040
Why?
Learning
1
1989
143
0.040
Why?
Health Education
1
2008
76
0.040
Why?
Guideline Adherence
1
2008
83
0.040
Why?
Quality Indicators, Health Care
1
2007
55
0.040
Why?
Patient Acceptance of Health Care
1
2008
113
0.040
Why?
Attitude of Health Personnel
2
1979
293
0.040
Why?
Body Mass Index
1
2008
211
0.040
Why?
Incidence
1
2009
679
0.040
Why?
Lymphotoxin-beta
1
2006
8
0.040
Why?
Lymphotoxin-alpha
1
2006
11
0.040
Why?
Physicians, Family
1
2008
113
0.040
Why?
Interleukin-18
1
2006
11
0.040
Why?
Cancer Care Facilities
1
2006
9
0.030
Why?
Cell Proliferation
1
2010
521
0.030
Why?
Drug Evaluation, Preclinical
1
2006
79
0.030
Why?
Mice, Inbred C3H
1
2006
229
0.030
Why?
Fibrosis
1
2006
65
0.030
Why?
Radiotherapy, Adjuvant
1
2006
73
0.030
Why?
Chemotherapy, Adjuvant
1
2006
88
0.030
Why?
Adrenal Cortex Hormones
1
1986
99
0.030
Why?
Gamma Rays
1
2006
69
0.030
Why?
Nurse-Patient Relations
1
2005
7
0.030
Why?
Epidemiologic Methods
1
1985
55
0.030
Why?
Radiation Dosage
1
2005
126
0.030
Why?
Methotrexate
1
1985
71
0.030
Why?
Practice Guidelines as Topic
1
2008
304
0.030
Why?
Anoxia
1
1986
158
0.030
Why?
Pneumonia, Pneumocystis
1
1986
119
0.030
Why?
Tape Recording
1
1984
21
0.030
Why?
Respiration, Artificial
1
1986
175
0.030
Why?
Sweating
1
1984
6
0.030
Why?
Internal-External Control
1
2005
42
0.030
Why?
Physician's Practice Patterns
1
2008
253
0.030
Why?
Alopecia
1
2004
20
0.030
Why?
Death
1
1984
23
0.030
Why?
Interview, Psychological
2
1981
76
0.030
Why?
Depressive Disorder
1
2008
321
0.030
Why?
Human Experimentation
1
1984
16
0.030
Why?
Pain Measurement
1
1986
243
0.030
Why?
Combined Modality Therapy
1
2005
486
0.030
Why?
Oxygen
1
1986
500
0.030
Why?
New England
1
2002
24
0.030
Why?
Feces
1
1982
80
0.030
Why?
Pregnancy Complications
1
2004
196
0.030
Why?
Odors
1
1982
7
0.030
Why?
Random Allocation
1
1982
254
0.030
Why?
Cross-Over Studies
1
2002
126
0.030
Why?
Fear
1
1982
46
0.030
Why?
Neurons
1
2010
1108
0.030
Why?
Membrane Proteins
1
2006
553
0.030
Why?
Colonic Neoplasms
1
1982
123
0.030
Why?
Probability
1
1982
294
0.020
Why?
Reference Values
1
2002
441
0.020
Why?
Outpatient Clinics, Hospital
1
1981
41
0.020
Why?
Infant
2
1968
2249
0.020
Why?
Electromyography
1
2001
174
0.020
Why?
Electrophysiology
1
2001
247
0.020
Why?
Reading
1
1980
20
0.020
Why?
Documentation
1
1980
34
0.020
Why?
Personal Satisfaction
1
1980
34
0.020
Why?
Medicine
1
1980
30
0.020
Why?
Physical Examination
1
1980
88
0.020
Why?
Specialization
1
1980
42
0.020
Why?
Breast Neoplasms, Male
1
1999
6
0.020
Why?
Lung
1
1986
1142
0.020
Why?
Truth Disclosure
1
1979
23
0.020
Why?
RNA, Messenger
1
2006
1857
0.020
Why?
Arrhythmias, Cardiac
1
2001
248
0.020
Why?
Vanilmandelic Acid
1
1978
6
0.020
Why?
Clinical Competence
1
1981
262
0.020
Why?
Epinephrine
1
1978
141
0.020
Why?
Norepinephrine
1
1978
257
0.020
Why?
Collagen
2
1966
299
0.020
Why?
Arrhythmia, Sinus
1
1995
7
0.020
Why?
Skin Temperature
1
1995
8
0.020
Why?
Infant, Premature
2
1966
233
0.020
Why?
Monitoring, Physiologic
1
1995
102
0.020
Why?
Myocardial Infarction
1
1978
681
0.010
Why?
Appointments and Schedules
2
1981
34
0.010
Why?
Genes, Recessive
1
1968
38
0.010
Why?
Amino Acid Oxidoreductases
1
1967
39
0.010
Why?
Acidosis
1
1968
126
0.010
Why?
Fetus
1
1967
257
0.010
Why?
Adjustment Disorders
1
1985
11
0.010
Why?
Delirium, Dementia, Amnestic, Cognitive Disorders
1
1985
20
0.010
Why?
Drug Utilization
1
1985
47
0.010
Why?
Animals, Newborn
1
1967
505
0.010
Why?
Therapeutic Human Experimentation
1
1984
4
0.010
Why?
Consent Forms
1
1984
4
0.010
Why?
Trust
1
1984
30
0.010
Why?
Patient Participation
1
1984
74
0.010
Why?
Occupations
1
1983
13
0.010
Why?
Interviews as Topic
1
1984
181
0.010
Why?
Marriage
1
1983
37
0.010
Why?
Physician's Role
1
1984
132
0.010
Why?
Liver
1
1967
876
0.010
Why?
Personality Disorders
1
1983
48
0.010
Why?
Mental Health
1
1983
85
0.010
Why?
Reality Testing
1
1982
1
0.010
Why?
Psychomotor Agitation
1
1982
43
0.010
Why?
Anti-Anxiety Agents
1
1979
19
0.010
Why?
Drug Prescriptions
1
1979
42
0.010
Why?
Rats
1
1967
4386
0.010
Why?
Social Change
1
1979
22
0.010
Why?
Referral and Consultation
1
1981
198
0.010
Why?
Patient Advocacy
1
1979
50
0.010
Why?
Hypnotics and Sedatives
1
1979
84
0.010
Why?
Antipsychotic Agents
1
1979
116
0.000
Why?

Visualizations


Morrow's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department